Advertisement
Forex-Nachrichten
Japan Producer Price Data Due On Wednesday
Japan will on Wednesday release August figures for producer prices, highlighting a light day for Asia-Pacific economic activity.
RTTNews |
vor 638 Tagen
South Korea Export Prices Slump 7.9% On Year In August
Producer prices in Japan were down 7.9 percent on year in August, the Bank of Japan said on Wednesday - moderating from the 12.8 percent drop in July.
RTTNews
|
vor 638 Tagen
TSX Ends Modestly Higher
The Canadian market ended modestly higher on Tuesday, thanks largely to strong gains posted by energy stocks after oil prices rose on supply concerns.
RTTNews
|
vor 638 Tagen
Dollar Gains Against Major Counterparts Ahead Of Inflation Data
The U.S. dollar climbed higher on Tuesday, recovering from recent weakness, ahead of crucial economic data, including reports on consumer and producer price inflation and retail sales.
RTTNews
|
vor 638 Tagen
Swiss Market Ends Marginally Higher
The Switzerland stock market ended marginally up on Tuesday after moving in tight range slightly above the flat line right through the day's trading session.
RTTNews
|
vor 638 Tagen
European Stocks Close Broadly Lower After Choppy Session
European stocks closed broadly lower on Tuesday after a choppy session, with investors staying somewhat cautious ahead of the release of a slew of crucial economic data, including consumer and producer price inflation from the U.S., and the monetary policy meeting of the European Central Bank.
RTTNews
|
vor 638 Tagen
Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery
Walgreens, a division of Walgreens Boots Alliance, Inc. (WBA), has inked a partnership with Pearl Health to boost and expand value-based care to patients in Medicare in partnership with community-based primary care physicians. The partnership with Pearl Health will enable Walgreens to transition quickly and effectively to value-based care and improve outcomes in the communities they serve.
RTTNews
|
vor 638 Tagen
more news
U.S. Dollar Strengthens Against Majors
The U.S. dollar firmed against its major opponents in the European session on Tuesday.
RTTNews
|
vor 638 Tagen
Kohl's Unveils Top 20 Toys Of 2023 Holiday Season
Retailer Kohl's Corp. has unveiled the list of top 20 toys as the 2023 holiday season is kicking off. The top 20 toys include Squishmallows, Magic Mixies Genie Lamp, Magic Whispers Lune and Skye, Little Live Pets My Puppy's Home, Disney Princess Royal Adventures Castle and LEGO Ariel's Treasure Chest, among others.
RTTNews
|
vor 638 Tagen
Intel To Divest About 10% Stake In IMS Nanofabrication Business To TSMC
Intel Corp. (INTC) announced Tuesday that it has agreed to sell an approximately 10% stake in the IMS Nanofabrication business to Taiwan Semiconductor Manufacturing Co. Ltd. or TSMC (TSM).
RTTNews
|
vor 638 Tagen
German Housing Construction Cancellations At New High - Ifo
Germany's residential construction sector crisis continued to intensify in August with the number of project cancellations hitting a new high, mainly due to rising costs and higher interest rates, a survey from the ifo Institute revealed Tuesday. In August, 20.7 percent of companies reported canceled housing projects, up from 18.9 percent in the previous month.
RTTNews
|
vor 638 Tagen
Tesla Gains On Morgan Stanley's Optimistic View On Dojo Supercomputer
Tesla Inc. shares increased more than 10 percent in the regular trading on Monday after Morgan Stanley said its Dojo supercomputer could add $500 billion in the electric vehicle maker's market value. Analysts at Morgan Stanley said that Dojo would potentially unlock new revenue streams through wider adoption of robotaxis and software services.
RTTNews
|
vor 638 Tagen
AbbVie Reports Top-line Results From Phase 3 SEQUENCE Clinical Trial Of Risankizumab
Biopharmaceutical company AbbVie, Inc. (ABBV) announced Tuesday top-line results from the Phase 3 SEQUENCE clinical trial evaluating risankizumab (SKYRIZI, 600 mg intravenous [IV] induction at week 0, 4 and 8 and 360 mg subcutaneous injection [SC] starting at week 12 and every 8 weeks thereafter) versus ustekinumab (STELARA, IV dose at week 0 and 90 mg SC every 8 weeks thereafter) through week 48 in patients with moderately to severely active Crohn's disease who have failed one or more anti-TNFs.
RTTNews
|
vor 638 Tagen
Stay up to date!
Add Nachrichten to your browser
Add To Chrome
